Aristotle University Of Thessaloniki (AUTH)
Φλεγμονώδεις κυτταροκίνες και αντίσταση στην ινσουλίνη σε ινσουλινο-θεραπευόμενους διαβητικούς ασθενείς τύπου 2
Abstract
dc:descriptionRecent evidence suggests that low grade inflammation possibly plays a significant role in the pathogenesis of type 2 diabetes (Type 2 DM). The hypothesis is that the inflammatory process is starting perhaps in the adipose tissue due to the growing lipid cells in obese subjects. The adipocytes can excrete various inflammatory mediators, such as inflammatory cytokines IL-6 and TNF-α. These inflammatory cytokines can promote an inflammatory state in the whole body, and this situation can cause disturbance of the homeostasis of glucose and lead to the pathogenesis of diabetes mellitus. Our study was designed to investigate the existence of a low grade inflammatory status in a subgroup of patients with type 2 diabetes mellitus under insulin therapy. More over a purpose of our study was to examine the possible associations between markers of inflammation and insulin resistance with anthropometric data of the patients, as well as with parameters of diabetes and obesity. Finally, aim of the study was to investigate the possible correlation of inflammation with the needs of insulin/Kg Body Weight (IU Insulin/KgBW). To the best of our knowledge, this is the first study to evaluate the above parameters in this particular subgroup of patients. Evaluated variables in our study were: sex, age, Body Mass Index (BMI), Waist Circumference, Waist to Hip ratio, duration of diabetes, total IU Insulin/24h, duration of insulin therapy, IU Ins/KgBW, glycosylated hemoglobin (HbA1c), microalbuminuria, serum glucose, markers of insulin resistance (insulin, proinsulin, c-peptide, HOMA-IR), the existence of risk factors for cardiovascular disease (hypertension, dyslipidemia, coronary heart disease, cardiac failure) and inflammatory markers such as: Erythrocyte Sedimentation Rate (ESR), White Blood Cells (WBC), C-Reactive Protein (CRP), the cytokines IL-6 and TNF-α and the soluble receptors of TNF-α, sTNR-60 and sTNFR-80. A total of 174 patients divided in three groups, was examined. Group A included 85 patients with type 2 DM under insulin therapy, group B 32 patients with DM type 2 under treatment with sulfonylurea (Oral Hypoglycemic Agent, OHA) and group C 57 patients without diabetes. In order to examine the correlation of the inflammation markers with the needs of insulin (IU insulin/Kgr BW) for the same level of diabetes control, group A was divided into two subgroups, according to the level of glycemic control: subgroup A1 (HbA1c≤7,5) and subgroup A2 (HbA1c>7,5). The patients in groups A, B, and C were matched for age, sex and BMI. Comparing groups A and C for inflammatory markers, higher values were determined in group A than in group C for WBC (p=0.002), CRP (p=0.007), IL-6 (p=0.030), TNF-α (p=0.003) and sTNFR-60 (p=0.001). Comparing groups A and C for markers of insulin resistance, higher values were detected in the first group for insulin (p=0.001) and HOMA-IR (p=0.001). The comparison between groups A and B for the inflammatory markers indicated higher values in group A for cytokines IL-6 (p=0,001), TNF-α (p=0.016) and the receptor sTNFR-60 (p=0.005). The comparison between the two groups for the markers of insulin resistance showed significantly greater values in group A for insulin (p=0.001) and HOMA-IR (p=0.001) and significantly greater values in group B for c-peptide (p=0.012) and proinsulin (p=0.029). The comparison between groups B and C, for the markers of inflammation, indicated greater mean values for CRP (p=0.001) in group B than in group C and higher mean values were determined in the first group (B) for the markers of insulin resistance: c-peptide (p=0.001), proinsulin (p=0.001) and HOMA-IR (p=0.008). Considering group A, we investigated the possible relationship between inflammation and obesity. Significant associations were determined between ESR and WC, and between CRP and BMI and WC. A positive correlation was found between the TNF-α receptors (sTNFR-60, sTNFR-80) and the duration of diabetes, in the same group. Moreover a significant correlation between WBC and HbA1c was found in group A. In the same analysis, a positive correlation was found between sTNFR-60 and triglycerides. The inflammatory markers, ESR and sTNFR-60 presented significant correlations with microalbuminuria, while sTNFR-60 was related to the age of the patients in group A. In the same analysis, the relationship of inflammation and insulin resistance was confirmed, by a positive correlation between ESR and c-peptide. Our hypothesis that perhaps inflammation and needs of insulin for the same level of diabetes control are connected, was not confirmed. When the two groups of diabetic patients (A+B) were examined as a total, significant correlations between inflammatory markers (ESR, CRP and sTNFR-60) and obesity (WC), were observed. Moreover ESR, IL-6, TNF-α, sTNFR-60 and sTNFR-80 were positively related to the duration of diabetes and also inflammatory markers (ESR, WBC, CRP, IL-6 and sTNFR-60) were related to HbA1c. The correlations of inflammation with microalbuminuria in this analysis, were the same observed in group A. Similarly the receptors sTNFR-60 and sTNFR-80 were positively correlated with age. Lastly, in the same analysis, the inflammation and insulin resistance was found to be correlated: ESR was related to c-peptide, IL-6 was related to insulin, and TNF-α was related to insulin and HOMA-IR. When all patients of the study were examined as a total, significant correlations of the inflammatory markers were determined: (i) with obesity (ESR, CRP, IL-6 and sTNFR-60 were positively related with WC, and CRP, sTNFR-60 were positively with WHR), (ii) with control of diabetes (ESR, WBC, CRP, IL-6 and sTNFR-60 with HbA1c) and (iii) with glucose homeostasis (WBC, CRP with glucose). Similarly ESR, CRP and sTNFR-60 were positively related with triglycerides and ESR, CRP, IL-6 and sTNFR-60 were positively related to microalbuminuria. Moreover the relationship between inflammation (ESR, sTNFR-60 and sTNFR-80) and age was confirmed in these patients too. Lastly, the inflammatory markers and the markers of insulin in this analysis were also related (ESR with c-peptide, CRP, IL-6, TNF-α, and sTNFR-60 with insulin and HOMA-IR). In group A, insulin resistance (c-peptide) was related to the age of the patients. Also HOMA-IR was related to serum glucose and HbA1c and concentrations of proinsulin were correlated with WHR. In group A+B, a significant negative correlation of proinsulin with duration of diabetes, was detected and at the same time a significant positive relation of insulin and HOMA-IR with duration of diabetes was observed. Similarly a negative correlation of c-peptide with HbA1c was found, while a positive correlation of insulin and HOMA-IR with HbA1c was observed. HOMA-IR was also related with concentrations of glucose in diabetic patients (group A+B). In the same analysis insulin and triglycerides were found to be associated and c-peptide was related to age. Finally in group A+B. a significant association was found between insulin and WC. In group A+B+C, significant correlations of the markers of insulin resistance were determined: with age (c-peptide), microalbuminuria (HOMA-IR), HbA1c and glucose (proinsulin, insulin and HOMA-IR). Negative associations between proinsulin, insulin and HOMA-IR with HDL were observed and at same time, positive associations between all markers and triglycerides were found. Lastly, insulin resistance was correlated to obesity in all patients (insulin and HOMA-IR with BMI, all markers with WC and proinsulin, insulin and HOMA-IR with WHR). In conclusion, from the findings of our study, can be suggested that the subgroup of patients with type 2 DM under insulin therapy, presents a status of inflammation and insulin resistance in a greater level than diabetic patients in therapy with OHA and obese patients without diabetes. Chronic inflammation in these patients presents significant correlations with obesity, duration of diabetes, control of diabetes, age, microalbuminuria, hyperlipidemia and insulin resistance. The level of inflammatory activation in patients with type 2 DM under insulin therapy is insufficient to increase the needs of insulin for the control of the disease. Insulin resistance in these patients was found to be associated with obesity, control of diabetes, hyperlipidemia and aging. The associations of inflammation and insulin resistance observed, were confirmed when all diabetic subjects of the study were examined together and even more when all subjects of the study were examined as a total. From the above, it can be hypothesized that chronic inflammation could lead to the impaired glucose homeostasis and the pathogenesis of diabetes. It can be further assumed that diabetes, accompanied by its complications that developed with time, may promote the inflammatory activation.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Μαυρίδης, Γεώργιος
- Mavridis, Georgios
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19071